Sodium nitrite attenuates hypertension-in-pregnancy and blunts increases in soluble fms-like tyrosine kinase-1 and in vascular endothelial growth factor
dc.contributor.author | Gonçalves-Rizzi, Victor Hugo [UNESP] | |
dc.contributor.author | Possomato-Vieira, Jose Sergio [UNESP] | |
dc.contributor.author | Sales Graça, Tamiris Uracs [UNESP] | |
dc.contributor.author | Nascimento, Regina Aparecida [UNESP] | |
dc.contributor.author | Dias-Junior, Carlos A. [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2018-12-11T17:02:58Z | |
dc.date.available | 2018-12-11T17:02:58Z | |
dc.date.issued | 2016-07-01 | |
dc.description.abstract | Preeclampsia is a pregnancy-associated disorder characterized by hypertension with uncertain pathogenesis. Increases in antiangiogenic soluble fms-like tyrosine kinase-1 (sFlt-1) and reductions in nitric oxide (NO) bioavailability have been observed in preeclamptic women. However, the specific mechanisms linking these detrimental changes to the hypertension-in-pregnancy are not clearly understood. In this regard, while recent findings have suggested that nitrite-derived NO formation exerts antihypertensive and antioxidant effects, no previous study has examined these responses to orally administered nitrite in hypertension-in-pregnancy. We then hypothesized restoring NO bioavailability with sodium nitrite in pregnant rats upon NO synthesis inhibition with N(omega)-nitro-l-arginine methyl ester (L-NAME) attenuates hypertension and high circulating levels of sFlt-1. Number and weight of pups and placentae were recorded to assess maternal-fetal interface. Plasma sFlt-1, vascular endothelial growth factor (VEGF) and biochemical determinants of NO formation and of antioxidant function were measured. We found that sodium nitrite blunts the hypertension-in-pregnancy and restores the NO bioavailability, and concomitantly prevents the L-NAME-induced high circulating sFlt-1 and VEGF levels. Also, our results suggest that nitrite-derived NO protected against reductions in litter size and placental weight caused by L-NAME, improving number of viable and resorbed fetuses and antioxidant function. Therefore, the present findings are consistent with the hypothesis that nitrite-derived NO may possibly be the driving force behind the maternal and fetal beneficial effects observed with sodium nitrite during hypertension-in-pregnancy. Certainly further investigations are required in preeclampsia, since counteracting the damages to the mother and fetal sides resulting from hypertension and elevated sFlt-1 levels may provide a great benefit in this gestational hypertensive disease. | en |
dc.description.affiliation | Department of Pharmacology Biosciences Institute of Botucatu Sao Paulo State University (UNESP), Distrito de Rubiao Junior, S/N | |
dc.description.affiliationUnesp | Department of Pharmacology Biosciences Institute of Botucatu Sao Paulo State University (UNESP), Distrito de Rubiao Junior, S/N | |
dc.format.extent | 71-78 | |
dc.identifier | http://dx.doi.org/10.1016/j.niox.2016.05.004 | |
dc.identifier.citation | Nitric Oxide - Biology and Chemistry, v. 57, p. 71-78. | |
dc.identifier.doi | 10.1016/j.niox.2016.05.004 | |
dc.identifier.file | 2-s2.0-84969776534.pdf | |
dc.identifier.issn | 1089-8611 | |
dc.identifier.issn | 1089-8603 | |
dc.identifier.scopus | 2-s2.0-84969776534 | |
dc.identifier.uri | http://hdl.handle.net/11449/172978 | |
dc.language.iso | eng | |
dc.relation.ispartof | Nitric Oxide - Biology and Chemistry | |
dc.relation.ispartofsjr | 1,278 | |
dc.relation.ispartofsjr | 1,278 | |
dc.rights.accessRights | Acesso aberto | |
dc.source | Scopus | |
dc.subject | Hypertension-in-pregnancy | |
dc.subject | N(G)-nitro-l-arginine methyl ester | |
dc.subject | Rats | |
dc.subject | Sodium nitrite | |
dc.title | Sodium nitrite attenuates hypertension-in-pregnancy and blunts increases in soluble fms-like tyrosine kinase-1 and in vascular endothelial growth factor | en |
dc.type | Artigo | |
unesp.author.lattes | 6296664642422599[5] | |
unesp.author.orcid | 0000-0002-0348-6144[5] |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- 2-s2.0-84969776534.pdf
- Tamanho:
- 591.26 KB
- Formato:
- Adobe Portable Document Format
- Descrição: